Molecular Imaging: Page 44

PET/CT reveals vascular effects of chemotherapy in lymphoma patients

By Will Morton

PET/CT imaging has shown for the first time in a clinical trial that aortic inflammation is reduced in lymphoma patients after first-line chemotherapy, according to a study published March 31 in JACC: Advances.

April 6, 2023

Are Alzheimer's disease risk factors sex-specific?

By Will Morton

Researchers have identified sex-specific risk factors that may explain why some cognitively unimpaired women have higher brain pathology linked to Alzheimer's disease (AD), according to a study published April 3 in JAMA Neurology.

April 3, 2023

SPECT/CT helps assess patients with knee pain following arthroplasty

By Will Morton

SPECT/CT imaging is an effective way to evaluate noninfected painful knees in patients after they have undergone knee arthroplasty, a literature review published March 21 in the Journal of Orthopaedic Surgery and Research has found.

April 2, 2023

Ablaze secures peptide drug license from RayzeBio

By AuntMinnie.com staff writers

Ablaze Pharmaceuticals has licensed a peptide drug candidate from RayzeBio that it will develop to target the liver cancer biomarker GPC3. Ablaze plans to market the new drug in China, where the company is headquartered.

March 30, 2023

Getz Healthcare, Subtle Medical ink distribution deal

By AuntMinnie.com staff writers

Australian medical equipment and software provider Getz Healthcare has signed on as a distributor for artificial intelligence (AI) software developer Subtle Medical.

March 28, 2023

Michael J. Fox Foundation updates imaging competition

By AuntMinnie.com staff writers

The Michael J. Fox Foundation for Parkinson's Research has named Merck as the winner of its Ken Griffin Alpha-synuclein Imaging Competition.

March 27, 2023

On Target Laboratories touts Cytalux study results

By AuntMinnie.com staff writers

Molecular imaging agent developer On Target Laboratories is highlighting clinical results from a phase III study of its Cytalux injection for intraoperative imaging of lung cancer.

March 26, 2023

PET/CT shows promise in patients with IgG4-RD

By Will Morton

F-18 FDG-PET/CT may be a valuable tool for identifying cardiovascular manifestations in patients with immunoglobulin G4-related disease (IgG4-RD), according to a study published March 17 in EJNMMI Research.

March 21, 2023

IMV: PET prostate scan volumes saw robust growth in 2022

By Davin Korstjens

PET prostate scan volumes grew 46% year-over-year, showing an increase of 3 percentage points to produce 9% of the overall procedure mix by study type, according to the newly published IMV 2023 PET Market Summary Report.

March 20, 2023

PET/CT reveals how COVID-19 manifests in critically ill patients

By Will Morton

In a pictorial essay, Dutch researchers are highlighting findings from whole-body F-18 FDG-PET/CT imaging that show how COVID-19 manifests in critically ill patients hospitalized for the disease.

March 19, 2023

Telix gets FDA nod for gallium injection prep kit

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has cleared Telix Pharmaceuticals' gallium-68 (Ga-68) gozetotide injection (Illuccix) preparation kit.

March 15, 2023

Curium confirms no supply challenges for Eclipse trial

By AuntMinnie.com staff writers

Nuclear medicine company Curium confirmed in a recent statement that it doesn't expect supply challenges of its lutetium-177 prostate-specific membrane antigen with 3-iodo-D-tyrosine for the company's Eclipse phase III clinical trial.

March 15, 2023

Previous Page

Page 44 of 612

Next Page